Derek Small's equity holdings have seen significant ups and downs, primarily peaking at approximately $19.56 million in mid-2020 before gradually declining. His holdings grew steadily from around $8.04 million in September 2019, as Assembly began to capture investor interest, to...
Derek Small's equity holdings have seen significant ups and downs, primarily peaking at approximately $19.56 million in mid-2020 before gradually declining. His holdings grew steadily from around $8.04 million in September 2019, as Assembly began to capture investor interest, to this peak in July 2020. After that, his wealth was mostly tied up in these holdings which experienced natural market fluctuations. Throughout 2021 and 2022, his holdings dropped, reflecting the volatility common in biotech stocks—a reminder that this industry can be unpredictable. By the end of 2022, his holdings were down to about $1.5 million, showing a steady decline as the market reacted to various factors affecting the biotechnology sector. This trajectory underscores the challenges that come with innovations in healthcare, as well as the importance of strategic planning in managing personal wealth amid market changes.